Supreme Court won’t take up PhRMA-Arkansas 340B expansion casenews2024-12-09T20:44:59+00:00December 9th, 2024|Endpoints News|
Person of interest arrested in connection with UnitedHealthcare CEO killingnews2024-12-09T19:51:42+00:00December 9th, 2024|Endpoints News|
Biosecure bill is left out of end-of-year defense packagenews2024-12-08T02:00:38+00:00December 8th, 2024|Endpoints News|
Biosecure compromise could add review process for named companies, sources saynews2024-12-05T19:18:15+00:00December 5th, 2024|Endpoints News|
Kiromic and SEC settle over undisclosed clinical trial holdsnews2024-12-03T19:50:13+00:00December 3rd, 2024|Endpoints News|
Bristol Myers sues the federal government over 340B, following other drugmakersnews2024-11-27T15:43:42+00:00November 27th, 2024|Endpoints News|
Sanofi introduces new 340B payment model — reportnews2024-11-22T20:00:19+00:00November 22nd, 2024|Endpoints News|
Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compoundersnews2024-11-22T19:58:06+00:00November 22nd, 2024|Endpoints News|
Senate committee advances pharma patent challenge billnews2024-11-22T17:19:17+00:00November 22nd, 2024|Endpoints News|
BeiGene settles final suit over future Brukinsa genericsnews2024-11-19T19:17:26+00:00November 19th, 2024|Endpoints News|
